Cargando…

Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin

BACKGROUND: Glucocorticoid (GC)-induced hyperglycemia is characterized by elevated postprandial blood glucose, which commonly requires multiple insulin injections. We investigated whether a long-acting glucagon-like peptide-1 receptor agonist, dulaglutide (Dula), safely improved GC-induced hyperglyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchinuma, Hiroyuki, Ichijo, Masashi, Harima, Noriyuki, Tsuchiya, Kyoichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203793/ https://www.ncbi.nlm.nih.gov/pubmed/32381085 http://dx.doi.org/10.1186/s12902-020-0542-5

Ejemplares similares

Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat
por: Harai, Nozomi, et al.
Publicado: (2023)

Acute Kidney Injury with Hemolysis after Glycerin Enema-induced Rectal Injury in a Patient with Type 2 Diabetes
por: Hayashida, Ryosuke, et al.
Publicado: (2020)

Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice
por: Mori, Kentaro, et al.
Publicado: (2023)

Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia
por: Cheng, Yu-Chien, et al.
Publicado: (2021)

Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients
por: Gonzalez-Gonzalez, Jose Gerardo, et al.
Publicado: (2013)

Management of Glucocorticoid-Induced Hyperglycemia
por: Shah, Parag, et al.
Publicado: (2022)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity
por: Li, Gerui
Publicado: (2020)

Liver Sinusoidal Endothelial Cells Link Hyperinsulinemia to Hepatic Insulin Resistance
por: Tsuchiya, Kyoichiro, et al.
Publicado: (2013)

Comparison of the injection‐site experience of the starting doses with semaglutide and dulaglutide: A randomized, double‐blind trial in healthy subjects
por: Snitker, Søren, et al.
Publicado: (2021)

Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
por: MacIsaac, Richard J.
Publicado: (2020)

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Closed-loop management of inpatient hyperglycemia
por: Boughton, Charlotte K., et al.
Publicado: (2019)

Inpatient Hyperglycemia Management and COVID-19
por: Bellido, Virginia, et al.
Publicado: (2020)

Glucocorticoid receptor activation reduces food intake independent of hyperglycemia in zebrafish
por: Nipu, Niepukolie, et al.
Publicado: (2022)

Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes
por: Huang, Jinxin, et al.
Publicado: (2023)

Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review
por: Houssarini, Jared A., et al.
Publicado: (2021)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

Management of Inpatient Hyperglycemia and Diabetes in Older Adults
por: Umpierrez, Guillermo E., et al.
Publicado: (2017)

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
por: Kim, Youngsook, et al.
Publicado: (2022)

Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes
por: Jones, Gregory C., et al.
Publicado: (2016)

Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens
por: Quintanilla-Flores, Dania Lizet, et al.
Publicado: (2017)

Association between maternal gestational diabetes mellitus and high‐sensitivity C‐reactive protein levels in 8‐year‐old children: The Yamanashi Adjunct Study of the Japan Environment and Children’s Study (JECS)
por: Sekine, Tetsuo, et al.
Publicado: (2022)

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review
por: Brooks, Danielle, et al.
Publicado: (2022)

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
por: Cui, Ling, et al.
Publicado: (2020)

Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
por: Onishi, Yukiko, et al.
Publicado: (2020)

Association Between Inpatient Sleep Loss and Hyperglycemia of Hospitalization
por: DePietro, Regina H., et al.
Publicado: (2017)

Inpatient hyperglycemia: Clinical management needs in teaching hospital()
por: Tamez-Pérez, H.E., et al.
Publicado: (2014)

Mode of administration of dulaglutide: implications for treatment adherence
por: Amblee, Ambika
Publicado: (2016)

Dulaglutide Alleviates LPS-Induced Injury in Cardiomyocytes
por: Wang, Rijun, et al.
Publicado: (2021)

Exacerbation of atrial fibrillation related to dulaglutide use
por: Lee, Jayden, et al.
Publicado: (2021)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

Gestational body weight gain and risk of low birth weight or macrosomia in women of Japan: a nationwide cohort study
por: Uchinuma, Hiroyuki, et al.
Publicado: (2021)

Association of glycated hemoglobin at an early stage of pregnancy with the risk of gestational diabetes mellitus among non‐diabetic women in Japan: The Japan Environment and Children’s Study
por: Sekine, Tetsuo, et al.
Publicado: (2021)

Rheumatoid arthritis - a neuroendocrine immune disorder: glucocorticoid resistance, relative glucocorticoid deficiency, low-dose glucocorticoid therapy, and insulin resistance
por: Straub, Rainer H
Publicado: (2014)

Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals
por: Nakamura, Suguru, et al.
Publicado: (2021)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee, Jiwoo, et al.
Publicado: (2019)

Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
por: Delfs, Neele, et al.
Publicado: (2020)

Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
por: Mody, Reema, et al.
Publicado: (2019)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j21j1m2mca5u0dri5rn4d06uvc